Projects

RNDr. Mária Ileninová, PhD.

International

Finished
  • The potential protective role of siponimod in neurodegeneration/spinal cord injury.
    Program: Mobility
    Duration: 1. 1. 2023 – 31. 12. 2024

National

Current
  • Molecular-biological analysis of the mechanism of ischemic tolerance in mitigating the consequences of stroke by conditioning
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
  • Regulatory mechanisms of mutual communication between hypoxia-ischemia and inflammation during the acute and subacute phase of traumatic spinal cord injury and Siponimod treatment
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
  • Neuroprotective and regenerative potential of post-traumatic cure targeted to Angiotensin II receptors
    Program: SRDA
    Duration: 1. 7. 2023 – 30. 6. 2027
  • The effect of NG2 positive cell population on extent of damage and functional recovery following spinalal cord injury
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2026
Finished
  • The development of translationally relevant regenerative and reparative strategies after spinal cord trauma
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
  • Mechanisms of glutamate metabolism as a tool of ischemic tolerance
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2023
  • Regulation of M1/M2 polarization: the effect on neuron survival, axonal growth and functional recovery after spinal cord trauma
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2023
Employees